State Street’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $39K | Hold |
|
|||||
|
2023
Q1 | $51.5K | Hold |
|
|||||
|
2022
Q4 | $63.5K | Hold |
|
|||||
|
2022
Q3 | $88K | Hold |
|
|||||
|
2022
Q2 | $137K | Hold |
|
|||||
|
2022
Q1 | $245K | Buy |
|
|||||
|
2021
Q4 | $315K | Hold |
|
|||||
|
2021
Q3 | $464K | Hold |
|
|||||
|
2021
Q2 | $579K | Buy |
|
|||||
|
2021
Q1 | $54K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $78K | Sell |
|
|||||
|
2020
Q1 | $1.63M | Buy |
|
|||||
|
2019
Q4 | $2.44M | Buy |
|
|||||
|
2019
Q3 | $2.9M | Buy |
|
|||||
|
2019
Q2 | $4.78M | Buy |
|
|||||
|
2019
Q1 | $88K | Sell |
|
|||||
|
2018
Q4 | $49K | Sell |
|
|||||
|
2018
Q3 | $137K | Sell |
|
|||||
|
2018
Q2 | $176K | Sell |
|
|||||
|
2018
Q1 | $1.59M | Buy |
|
|||||
|
2017
Q4 | $2.11M | Buy |
|
|||||
|
2017
Q3 | $1.26M | Sell |
|
|||||
|
2017
Q2 | $2.7M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $356K | Buy |
|
|||||
|
2015
Q4 | $372K | Buy |
|